According to Deep Tide TechFlow, on August 7, Processa Pharmaceuticals (NASDAQ: PCSA) announced today that it has received a strategic investment and plans to incorporate Crypto Assets into its corporate financial management strategy. The company has hired LifeSci Capital as an advisor to assist in implementing the related strategies.
Processa indicated that this decision is aimed at diversifying its capital structure and enhancing financial flexibility. The company will explore the use of blockchain assets to support its clinical development projects while strictly adhering to regulatory stan
View OriginalProcessa indicated that this decision is aimed at diversifying its capital structure and enhancing financial flexibility. The company will explore the use of blockchain assets to support its clinical development projects while strictly adhering to regulatory stan